price
AD
NYSE · ADCT
ADC Therapeutics S.A.
Healthcare · Biotechnology
$1.44
Up+$0.08 (+5.56%)
Updated Oct 20, 2026, 10:36 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 507.9M
- P/E ratio
- -3.35
- Dividend yield
- 0.00%
- 52-week range
- $0.78 – $4.98
- Volume
- 575.62K
- Avg. volume
- 1.16M
Price performance · ADCT
ADCT price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 19, 2026
ADCT closed at $1.44 after 21 trading sessions, up 28.57% for the selected period.
- Last close
- $1.44
- Period change
- +28.57%
- Period low
- $1.08
- Period high
- $1.86
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | $1.40 | $1.49 | $1.39 | $1.44 | 575.62K |
| Oct 16, 2026 | $1.49 | $1.51 | $1.40 | $1.40 | 799.53K |
| Oct 15, 2026 | $1.47 | $1.565 | $1.46 | $1.49 | 1.33M |
| Oct 14, 2026 | $1.67 | $1.725 | $1.40 | $1.45 | 1.74M |
| Oct 13, 2026 | $1.86 | $1.86 | $1.625 | $1.70 | 3.33M |
| Oct 12, 2026 | $1.70 | $1.87 | $1.64 | $1.86 | 1.59M |
| Oct 9, 2026 | $1.58 | $1.83 | $1.56 | $1.73 | 3.14M |
| Oct 8, 2026 | $1.41 | $1.63 | $1.32 | $1.59 | 5.55M |
| Oct 7, 2026 | $1.25 | $1.44 | $1.235 | $1.42 | 1.75M |
| Oct 6, 2026 | $1.25 | $1.27 | $1.20 | $1.27 | 1.35M |
| Oct 5, 2026 | $1.12 | $1.26 | $1.11 | $1.23 | 1.75M |
| Oct 2, 2026 | $1.10 | $1.14 | $1.06 | $1.13 | 1.32M |
| Oct 1, 2026 | $1.20 | $1.201 | $1.07 | $1.08 | 862.27K |
| Sep 30, 2026 | $1.23 | $1.285 | $1.20 | $1.22 | 1.11M |
| Sep 29, 2026 | $1.27 | $1.29 | $1.20 | $1.23 | 781.02K |
| Sep 28, 2026 | $1.24 | $1.27 | $1.20 | $1.26 | 835.12K |
| Sep 25, 2026 | $1.26 | $1.285 | $1.21 | $1.27 | 1.08M |
| Sep 24, 2026 | $1.305 | $1.31 | $1.24 | $1.29 | 1.58M |
| Sep 23, 2026 | $1.24 | $1.32 | $1.21 | $1.31 | 1.97M |
| Sep 22, 2026 | $1.13 | $1.25 | $1.12 | $1.23 | 1.67M |
| Sep 21, 2026 | $1.05 | $1.13 | $1.035 | $1.12 | 1.9M |
Latest ADCT news
The latest Smart Investors Daily articles mentioning ADCT.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

